Serif Yilmaz

Serif Yilmaz

Auto-generated profile, based on publicly available information

Serif Yilmaz

Department of Gastroenterology, Dicle University Faculty of Medicine, Diyarbakir, Turkey

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2005 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
ŞYŞerif Yilmaz
Şerif Yilmaz
MDMehmet Dursun
Mehmet Dursun
MEMelikşah Ertem
Melikşah Ertem
FCFikri Canoruc
Fikri Canoruc
ATAyşe Turhanoğlu
Ayşe Turhanoğlu
Even though studies on the epidemiology of the irritable bowel syndrome (IBS) are increasing day by day, epidemiological data are still unknown in many regions. Our objective was to determine the IBS prevalence, factors associated with this prevalence and probable risk groups in Southeastern Anatolia. The total population in the target region is approximately 6 million. A total of 3000 people (1521 females and 1479 males) randomly selected by stratified cluster sampling were interviewed face-to-face by using a questionnaire comprising demographic features and the Rome II criteria which also included probable risk factors and questions related with Bristol scale stool form. The statistical analysis was performed by using a package program called epi info 2000. IBS prevalence was 10.2% according to the Rome II criteria in our region. Six hundred and twenty-five of 3000 subjects had gastrointestinal symptoms in the last 3 months. IBS rate was higher in women (12.4%) than in men (8.0%), and married subjects had higher IBS rates (11.6%) than singles (6.7%). Those differences were statistically significant (p = 0.000 for both). It was most common in the 35–54-year age group. No difference was observed in terms of settlement (rural/urban), age group, education and occupation. History of abortion in women increased the IBS risk by 1.8 times (p = 0.000 Crude odds ratios = 1.8 (1.3–2.6) 95% confidence intervals). Of the IBS patients, 48.1% had characteristics of diarrhoea-predominance, 38.9% constipation-predominance while 13.0% had none. There was a significant relation between dominant stool form and Bristol scale stool form. IBS prevalence is 10.2% in the first community-based study carried out in this specific subject in Southeastern Anatolia. The dominance of middle age and females remained significant.

17 November 2006 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
ŞYŞerif Yılmaz
Şerif Yılmaz
KBKadim Bayan
Kadim Bayan
YTYekta Tüzün
Yekta Tüzün
SBSabri Batun
Sabri Batun
AAAbdullah Altıntaş
Abdullah Altıntaş

21 August 2008 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
KBKadim Bayan
Kadim Bayan
YTYekta Tüzün
Yekta Tüzün
ŞYŞerif Yılmaz
Şerif Yılmaz
MDMehmet Dursun
Mehmet Dursun
FCFikri Canoruc
Fikri Canoruc

7 August 2008 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
KBKadim Bayan
Kadim Bayan
YTYekta Tüzün
Yekta Tüzün
ŞYŞerif Yılmaz
Şerif Yılmaz
NCNaime Canoruc
Naime Canoruc
MDMehmet Dursun
Mehmet Dursun

1 January 2006 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ŞYŞerif Yılmaz
Şerif Yılmaz
KBKadim Bayan
Kadim Bayan
YTYekta Tüzün
Yekta Tüzün
MDMehmet Dursun
Mehmet Dursun
FCFikri Canoruç
Fikri Canoruç
AIM: To compare the effect of intravenous and oral omeprazole in patients with bleeding peptic ulcers without high-risk stigmata. METHODS: This randomized study included 211 patients [112 receiving iv omeprazole protocol (Group 1), 99 receiving po omeprazole 40 mg every 12 h (Group 2)] with a mean age of 52.7. In 144 patients the ulcers showed a clean base, and in 46 the ulcers showed flat spots and in 21 old adherent clots. The endpoints were re-bleeding, surgery, hospital stay, blood transfusion and death. After discharge, re-bleeding and death were re-evaluated within 30 d. RESULTS: The study groups were similar with respect to baseline characteristics. Re-bleeding was recorded in 5 patients of Group 1 and in 4 patients of Group 2 (P = 0.879). Three patients in Group 1 and 2 in Group 2 underwent surgery (P = 0.773). The mean length of hospital stay was 4.6 ± 1.6 d in Group 1 vs 4.5 ± 2.6 d in Group 2 (P = 0.710); the mean amounts of blood transfusion were 1.9 ± 1.1 units in Group 1 vs 2.1 ± 1.7 units in Group 2 (P = 0.350). Four patients, two in each group died (P = 0.981). After discharge, a new bleeding occurred in 2 patients of Group 1 and in 1 patient of Group 2, and one patient from Group 1 died. CONCLUSION: We demonstrate that the effect of oral omeprazole is as effective as intravenous therapy in terms of re-bleeding, surgery, transfusion requirements, hospitalization and mortality in patients with bleeding ulcers with low risk stigmata. These patients can be treated effectively with oral omeprazole.

1 March 2003
Verified
Journal Article
Closed access
MDMehmet Dursun
Mehmet Dursun
MYMehmet Yaldiz
Mehmet Yaldiz
AIAbdurrahman Işıkdoğan
Abdurrahman Işıkdoğan
GYGülşen Yilmaz
Gülşen Yilmaz
FCFikri Canoruç
Fikri Canoruç
SYSerif Yilmaz
Serif Yilmaz
Primary squamous cell carcinoma of the stomach is extremely rare. To date, only 80 cases have been reported. A 65-year-old man with complaints of epigastric pain and cachexia for the past year is presented. He had a tumour with infiltration of the corpus and antrum of the stomach. The tumour was unresectable, and the patient died within 3 months.